Top Markets
#1 Bitcoin TRC20 Bitcoin TRC20 +11.31%
#2 Seeker Seeker +8.57%
#3 Cash Cat Cash Cat +6.38%
#4 龙虾 (Lobster) 龙虾 (Lobster) +6.01%
#5 Pons Pons +5.82%
#6 Arbitrum Arbitrum +5.71%
#7 Siacoin Siacoin +5.70%
#8 Story Story +5.50%
#9 Pump.fun Pump.fun +5.01%
#10 Unit Pump Unit Pump +5.01%
Coin of the day
Bitcoin TRC20 Bitcoin TRC20
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Rang în acțiuni #14050
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Preț acțiune
$0.88012714
Ultima sincronizare: 2026-08-31
Capitalizare de piață
$439.58M
Schimbare (1 zi)
-4.01%
Schimbare (1 an)
1,131.97%
Țară
FR
Tranzacționează Valerio Therapeutics S.A. (ALVIO)

Categorie

Healthcare
Venituri pentru Valerio Therapeutics S.A. (ALVIO)
Venituri în Sep 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Valerio Therapeutics S.A., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Valerio Therapeutics S.A. din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH